JP2024514962A5 - - Google Patents

Info

Publication number
JP2024514962A5
JP2024514962A5 JP2023565307A JP2023565307A JP2024514962A5 JP 2024514962 A5 JP2024514962 A5 JP 2024514962A5 JP 2023565307 A JP2023565307 A JP 2023565307A JP 2023565307 A JP2023565307 A JP 2023565307A JP 2024514962 A5 JP2024514962 A5 JP 2024514962A5
Authority
JP
Japan
Prior art keywords
composition
use according
sequence
optionally
aavrh74
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023565307A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024514962A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/025916 external-priority patent/WO2022226289A2/en
Publication of JP2024514962A publication Critical patent/JP2024514962A/ja
Publication of JP2024514962A5 publication Critical patent/JP2024514962A5/ja
Pending legal-status Critical Current

Links

JP2023565307A 2021-04-23 2022-04-22 筋ジストロフィーの遺伝子治療のためのaavrh74ベクター Pending JP2024514962A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163179097P 2021-04-23 2021-04-23
US63/179,097 2021-04-23
US202263327410P 2022-04-05 2022-04-05
US63/327,410 2022-04-05
PCT/US2022/025916 WO2022226289A2 (en) 2021-04-23 2022-04-22 Aavrh74 vectors for gene therapy of muscular dystrophies

Publications (2)

Publication Number Publication Date
JP2024514962A JP2024514962A (ja) 2024-04-03
JP2024514962A5 true JP2024514962A5 (cg-RX-API-DMAC7.html) 2025-05-01

Family

ID=81648417

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023565307A Pending JP2024514962A (ja) 2021-04-23 2022-04-22 筋ジストロフィーの遺伝子治療のためのaavrh74ベクター

Country Status (13)

Country Link
US (2) US20240181083A1 (cg-RX-API-DMAC7.html)
EP (1) EP4326857A2 (cg-RX-API-DMAC7.html)
JP (1) JP2024514962A (cg-RX-API-DMAC7.html)
KR (1) KR20240000542A (cg-RX-API-DMAC7.html)
AU (1) AU2022262407A1 (cg-RX-API-DMAC7.html)
BR (1) BR112023021495A2 (cg-RX-API-DMAC7.html)
CA (1) CA3217649A1 (cg-RX-API-DMAC7.html)
CL (2) CL2023003102A1 (cg-RX-API-DMAC7.html)
CO (1) CO2023015911A2 (cg-RX-API-DMAC7.html)
IL (1) IL307881A (cg-RX-API-DMAC7.html)
MX (1) MX2023012509A (cg-RX-API-DMAC7.html)
TW (1) TW202304954A (cg-RX-API-DMAC7.html)
WO (1) WO2022226289A2 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2623605T3 (en) 2007-04-09 2019-03-25 Univ Florida RAAV VECTOR COMPOSITIONS WITH TYROSIN MODIFIED CAPSIDE PROTEINS AND PROCEDURES FOR USE THEREOF
US12358954B2 (en) 2012-05-15 2025-07-15 University Of Florida Research Foundation, Incorporated Capsid-modified rAAV vector compositions and methods therefor
US10294281B2 (en) 2012-05-15 2019-05-21 University Of Florida Research Foundation, Incorporated High-transduction-efficiency rAAV vectors, compositions, and methods of use
KR20240095539A (ko) 2021-10-08 2024-06-25 디노 테라퓨틱스, 인코포레이티드 캡시드 변이체 및 이의 사용 방법
WO2024184781A1 (en) * 2023-03-03 2024-09-12 Universitat Heidelberg Engineered aav capsids

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6342886B2 (ja) * 2012-04-18 2018-06-13 ザ・チルドレンズ・ホスピタル・オブ・フィラデルフィアThe Children’S Hospital Of Philadelphia Aavカプシドバリアントを使用した高効率な遺伝子導入のための組成物及び方法
EP3221456B1 (en) 2014-11-21 2021-09-22 University of Florida Research Foundation, Inc. Genome-modified recombinant adeno-associated virus vectors
JP7785352B2 (ja) * 2019-08-14 2025-12-15 ユニバーシティー オブ フロリダ リサーチ ファンデーション, インク. 遺伝子治療のためのaavカプシドバリアント

Similar Documents

Publication Publication Date Title
TWI908746B (zh) 微小肌縮蛋白基因療法之構築體及其用途
CN112004925B (zh) 具有降低的肝向性的AAV9和AAVrh74的杂合重组腺相关病毒血清型
EP2940131B1 (en) Aav variant
JP2025106514A (ja) 脳内への特異性が増強されたウイルス組成物
JP2026027271A5 (cg-RX-API-DMAC7.html)
Foster et al. Gene therapy progress and prospects: Duchenne muscular dystrophy
CN109652385A (zh) 外显子2靶向U7snRNA多核苷酸构建体的重组腺相关病毒递送
JP2021528983A5 (cg-RX-API-DMAC7.html)
US20220347317A1 (en) Aavrh74 vectors for gene therapy of muscular dystrophies
CN113747926A (zh) 用于肌肉表达的杂合启动子
WO2020142714A1 (en) Aav expression cassette and aav vectors comprising the same
US20240409955A1 (en) Auf1 combination therapies for treatment of muscle degenerative disease
KR20250166360A (ko) 페이로드 전달을 위한 rgd-함유 펩티드
US20250066437A1 (en) Transgenic expression cassette for treating muscular dystrophy
US20250346921A1 (en) An optimized aav vector for gene therapy of muscular dystrophy
WO2023190935A1 (en) Method for treating myopathies by targeting titin gene
WO2025232917A1 (en) Novel liver detargeted aav variants and uses thereof
KR20250139307A (ko) 파지 벡터
CN117355603A (zh) 用于肌营养不良的基因治疗的aavrh74载体
TW202528335A (zh) 衣殼多肽及其使用方法(一)
WO2025125692A1 (en) Viral vector for transduction of adipocytes
WO2025039622A1 (zh) 经修饰的腺相关病毒载体及其在治疗中枢神经系统疾病中的用途
HK40030612A (en) Viral vector for the targeted transfer of genes in the brain and spinal cord
WO2021237104A1 (en) Methods and compositions to spread protein cargoes across multi-nucleated cells
IL293334A (en) Microdystrophin gene therapy constructs and uses thereof